| Market Cap | ₹8,791Cr |
| ROE | 41.47% |
| P/E Ratio(TTM) | 58.84 |
| EPS(TTM) | 24.43 |
| P/B Ratio | 14.50 |
| Dividend Yield | 0.51% |
| Industry P/E | 33.14 |
| Book Value | 99.14 |
| Debt to Equity | 0.10 |
| Face Value | 10 |
| Parent Organisation | Corona Remedies |
| NSE Symbol | CORONA |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Emcure Pharmaceuticals | NA (0.00%) | 35.84 | ||
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 40.72 | ||
| Wockhardt | NA (0.00%) | -441.96 | ||
| Cohance Lifesciences | NA (0.00%) | 54.71 |